KIDS · XBRL financial data

OrthoPediatrics financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (KIDS's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	71,078	98,049	—	—	—	—
Revenue from contracts with customers	71,078	98,049	122,289	148,732	204,727	236,348
Cost of goods and services sold	16,047	24,646	31,629	37,479	56,129	63,687
Gross profit	55,031	73,403	90,660	111,253	148,598	172,661
Research and development	5,273	5,543	8,014	10,196	11,034	9,102
General and administrative	38,317	46,061	59,383	75,421	102,789	119,832
Total operating expenses	81,786	91,427	116,059	138,004	183,608	211,899
Operating income (loss)	(26,755)	(18,024)	(25,399)	(26,751)	(35,010)	(39,238)
Interest expense	3,412	56	2,424	(198)	2,621	5,996
Other income (expense)	20	1,083	(1,796)	2,261	(1,068)	6,046
Income tax expense (benefit)	(723)	(1,128)	(4,947)	(338)	(4,107)	460
Net income (loss)	(32,944)	(16,260)	1,258	(20,974)	(37,822)	(39,648)
Earnings per share, basic USD per share	(1.82)	(0.84)	0.06	(0.92)	(1.64)	(1.69)
Earnings per share, diluted USD per share	(1.82)	(0.84)	0.06	(0.92)	(1.64)	(1.69)
Weighted average shares, basic thousands of shares	18,057	19,268	20,705	22,675	23,078	23,459
Weighted average shares, diluted thousands of shares	18,057	19,268	20,948	22,675	23,078	23,459

Fiscal years (KIDS's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	28,758	7,641	8,991	31,055	43,820	19,556
Short-term investments	55,141	45,902	109,299	49,251	25,013	41,295
Accounts receivable	17,212	17,942	24,800	34,617	42,357	53,838
Inventory	52,989	57,569	78,192	105,851	117,005	133,790
Prepaid and other current assets	2,618	3,229	3,966	3,750	7,021	5,876
Total current assets	158,429	133,648	226,719	226,496	237,173	256,419
Property and equipment, net	27,227	28,515	34,286	41,048	50,596	49,555
Right-of-use asset	—	297	259	1,084	8,237	12,048
Goodwill	70,511	72,349	86,821	83,699	93,844	109,269
Total assets	320,412	304,274	427,727	438,745	473,209	508,630
Accounts payable	10,038	9,325	11,150	12,649	8,908	18,786
Current portion of long-term debt	131	137	144	152	897	1,866
Total current liabilities	35,028	29,715	30,871	41,666	33,962	46,197
Long-term debt	1,044	907	763	9,908	72,956	99,818
Lease liability, non-current	—	—	—	660	5,661	8,939
Total liabilities	85,644	78,905	49,079	61,720	118,643	162,034
Accumulated deficit	(161,766)	(178,026)	(176,768)	(197,742)	(235,564)	(275,212)
Total stockholders' equity	234,768	225,369	378,648	377,025	354,566	346,596
Total liabilities and equity	320,412	304,274	427,727	438,745	473,209	508,630
Common shares outstanding (cover page) thousands of shares	19,658	19,745	22,993	23,549	24,287	25,279

Fiscal years (KIDS's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(32,944)	(16,260)	1,258	(20,974)	(37,822)	(39,648)
Stock-based compensation	6,196	5,842	6,679	10,526	13,548	17,778
Depreciation and amortization	8,010	10,680	13,099	17,385	19,080	21,119
Net cash from operating activities	(18,530)	(13,063)	(21,766)	(27,046)	(27,048)	(4,851)
Purchases of property and equipment	10,504	8,103	10,031	16,878	14,263	11,110
Net cash from investing activities	(69,693)	(7,411)	(113,371)	41,677	(13,162)	(43,629)
Proceeds from issuing common stock	70,207	0	139,282	0	0	—
Proceeds from long-term debt	0	0	31,000	—	—	—
Net cash from financing activities	46,732	6	135,974	7,301	53,135	23,975
Net change in cash	(41,895)	(21,126)	1,456	22,565	12,750	(24,157)

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Orthopediatrics	17,141	72,661	4,506*	26.1M	—	Q3 FY26 10-QSep 30, 2026
EBR Systems	59,350	2,637	(17,194)*	75.3M	5.0 quarters	Q2 FY26 10-QJun 30, 2026
Butterfly Network	122,301	32,598	(2,266)*	not reported	10.3 quarters	Q3 FY26 10-QSep 30, 2026
Outset Medical	35,005	31,635	(9,635)*	18.8M	15.3 quarters	Q2 FY26 10-QJun 30, 2026
Pulse Biosciences	101,620	434	(18,709)*	71.3M	5.4 quarters	Q2 FY26 10-QJun 30, 2026
ClearPoint Neuro	46,184	12,075	(20,100)	32.1M	6.6 quarters	Q3 FY26 10-QSep 30, 2026
Heartflow	34,362	64,082	(8,577)*	87.0M	19.0 quarters	Q2 FY26 10-QJun 30, 2026
Ceribell	41,989	29,341	(13,078)*	38.8M	7.8 quarters	Q3 FY26 10-QSep 30, 2026
Delcath Systems	47,521	29,133	5,712*	34.7M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.